1. Home
  2. RITM vs GRFS Comparison

RITM vs GRFS Comparison

Compare RITM & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RITM
  • GRFS
  • Stock Information
  • Founded
  • RITM 2011
  • GRFS 1940
  • Country
  • RITM United States
  • GRFS Spain
  • Employees
  • RITM N/A
  • GRFS N/A
  • Industry
  • RITM Real Estate Investment Trusts
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RITM Real Estate
  • GRFS Health Care
  • Exchange
  • RITM Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • RITM 6.1B
  • GRFS 7.2B
  • IPO Year
  • RITM N/A
  • GRFS 2006
  • Fundamental
  • Price
  • RITM $12.27
  • GRFS $9.68
  • Analyst Decision
  • RITM Strong Buy
  • GRFS Hold
  • Analyst Count
  • RITM 7
  • GRFS 1
  • Target Price
  • RITM $13.71
  • GRFS $10.30
  • AVG Volume (30 Days)
  • RITM 5.1M
  • GRFS 917.3K
  • Earning Date
  • RITM 10-28-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • RITM 8.16%
  • GRFS 1.47%
  • EPS Growth
  • RITM 9.18
  • GRFS 132.60
  • EPS
  • RITM 1.30
  • GRFS 0.53
  • Revenue
  • RITM $3,665,023,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • RITM N/A
  • GRFS $6.00
  • Revenue Next Year
  • RITM $3.99
  • GRFS $6.71
  • P/E Ratio
  • RITM $9.41
  • GRFS $24.04
  • Revenue Growth
  • RITM 16.59
  • GRFS 9.32
  • 52 Week Low
  • RITM $9.13
  • GRFS $6.19
  • 52 Week High
  • RITM $12.62
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • RITM 51.21
  • GRFS 37.86
  • Support Level
  • RITM $12.23
  • GRFS $9.79
  • Resistance Level
  • RITM $12.40
  • GRFS $9.99
  • Average True Range (ATR)
  • RITM 0.16
  • GRFS 0.20
  • MACD
  • RITM -0.03
  • GRFS -0.11
  • Stochastic Oscillator
  • RITM 27.55
  • GRFS 2.93

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: